Cyclerion Therapeutics (CYCN) Retained Earnings (2019 - 2025)

Cyclerion Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$271.0 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 1.32% year-over-year to -$271.0 million; the TTM figure through Dec 2025 stood at -$271.0 million (down 1.32% YoY), while the FY2025 annual figure was -$271.0 million, down 1.32% from the prior year.
• Retained Earnings was -$271.0 million for Q4 2025 at Cyclerion Therapeutics, roughly flat from -$270.2 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$16000.0 in Q2 2023 to a low of -$271.0 million in Q4 2025.
• Historically, Retained Earnings has averaged -$174.6 million across 5 years, with a median of -$234.7 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings soared 99.99% in 2023, then plunged 1680656.25% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$215.1 million in 2021, then surged by 99.99% to -$20000.0 in 2022, then sank by 1321985.0% to -$264.4 million in 2023, then decreased by 1.16% to -$267.5 million in 2024, then retreated by 1.32% to -$271.0 million in 2025.
• The last three Retained Earnings figures came in at -$271.0 million (Q4 2025), -$270.2 million (Q3 2025), and -$269.2 million (Q2 2025), per Business Quant data.